Biological actions of green tea catechins on cardiac troponin C

British Journal of Pharmacology

Volumn 161, Issue 5, 2010, Pages 1034-1043

  Tadano, Naoto ^a,b   Du, Cheng Kun ^a   Yumoto, Fumiaki ^c,d   Morimoto, Sachio ^a   Ohta, Mika ^a   Xie, Ming Fang ^a   Nagata, Koji ^c   Zhan, Dong Yun ^a   Lu, Qun Wei ^a   Miwa, Yoshikazu ^a   Takahashi Yanaga, Fumi ^a   Tanokura, Masaru ^c   Ohtsuki, Iwao ^d   Sasaguri, Toshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b ZENYAKU KOGYO CO LTD   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium sensitivity; Cardiomyopathy; Catechin; Gallate; Troponin

Indexed keywords

CALCIUM; CATECHIN; CATECHIN GALLATE; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN GALLATE; GALLOCCATECHIN; TROPONIN C; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DRUG MECHANISM; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HYPERTROPHIC CARDIOMYOPATHY; MALE; MEMBRANE PERMEABILITY; MOUSE; MYOFILAMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUARTZ CRYSTAL MICROBALANCE; RABBIT; TEA; TRANSGENIC MOUSE;

ANIMALS; CALCIUM; CARDIOMYOPATHY, HYPERTROPHIC; CATECHIN; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROFILAMENTS; MYOCARDIAL CONTRACTION; QUARTZ CRYSTAL MICROBALANCE TECHNIQUES; RABBITS; STEREOISOMERISM; TEA; TROPONIN C;

EID: 77958524192     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00942.x     Document Type: Article

References (34)

1. Ahmad F, Seidman JG, Seidman CE (2005). The genetic basis for cardiac remodeling. Annu Rev Genomics Hum Genet 6: 185-216.
2. Arts IC, Hollman PC, Feskens EJ, Bueno de Mesquita HB, Kromhout D (2001). Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 74: 227-232.
3. Chu K-M, Hu OY-P, Shieh S-M (1999). Cardiovascular effect and simultaneous pharmacokinetic and pharmacodynamic modeling of pimobendan in healthy normal subjects. Drug Metab Dispos 27: 701-709.
4. Chyu KY, Babbidge SM, Zhao X, Dandillaya R, Rietveld AG, Yano J et al. (2004). Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 109: 2448-2453.
5. Du CK, Morimoto S, Nishii K, Minakami R, Ohta M, Tadano N et al. (2007). Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res 101: 185-194.
6. 2+ activation and the inotropic effect of pimobendan: comparison with milrinone. Circ Res 63: 911-922.
7. Harada K, Morimoto S (2004). Inherited cardiomyopathies as a troponin disease. Jpn J Physiol 54: 307-318.
8. Kitano K, Nam KY, Kimura S, Fujiki H, Imanishi Y (1997). Sealing effects of (-)-epigallocatechin gallate on protein kinase C and protein phosphatase 2A. Biophys Chem 65: 157-164.
9. 2+ sensitivity of cardiac and skeletal muscle. Pflugers Arch 456: 787-800.
10. Lorenz M, Wessler S, Follmann E, Michaelis W, Dusterhoft T, Baumann G et al. (2004). A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279: 6190-6195.
11. 2+ desensitization. J Mol Cell Cardiol 35: 1421-1427.
12. Ludwig A, Lorenz M, Grimbo N, Steinle F, Meiners S, Bartsch C et al. (2004). The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem Biophys Res Commun 316: 659-665.
13. Marian AJ (2005). Clinical and molecular genetic aspects of hypertrophic cardiomyopathy. Curr Cardiol Rev 1: 53-63.
14. Mirza M, Marston S, Willott R, Ashley C, Mogensen J, McKenna W et al. (2005). Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype. J Biol Chem 280: 28498-28506.
15. Mizukami Y, Ono K, Du CK, Aki T, Hatano N, Okamoto Y et al. (2008). Identification and physiological activity of survival factor released from cardiomyocytes during ischaemia and reperfusion. Cardiovasc Res 79: 589-599.
16. Morimoto S (2008). Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res 77: 659-666.
17. Morimoto S (2009). Expanded spectrum of gene causing both hypertrophic cardiomyopathy and dilated cardiomyopathy. Circ Res 105: 313-315.
18. 2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. Am J Physiol 275: C200-C207.
19. 2+-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proc Natl Acad Sci USA 99: 913-918.
20. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA (2002). Tea consumption and mortality after acute myocardial infarction. Circulation 105: 2476-2481.
21. Okahata Y, Kawase M, Niikura K, Ohtake F, Furusawa H, Ebara Y (1998a). Kinetic measurements of DNA hybridization on an oligonucleotide-immobilized 27-MHz quartz crystal microbalance. Anal Chem 70: 1288-1296.
22. Okahata Y, Niikura K, Sugiura Y, Sawada M, Morii T (1998b). Kinetic studies of sequence-specific binding of GCN4-bZIP peptides to DNA strands immobilized on a 27-MHz quartz-crystal microbalance. Biochemistry 37: 5666-5672.
23. Robertson IM, Li MX, Sykes BD (2009). Solution structure of human cardiac troponin C in complex with the green tea polyphenol, (-)-epigallocatechin 3-gallate. J Biol Chem 284: 23012-23023.
24. Sasazuki S, Inoue M, Miura T, Iwasaki M, Tsugane S (2008). Plasma tea polyphenols and gastric cancer risk: a case-control study nested in a large population-based prospective study in Japan. Cancer Epidemiol Biomarkers Prev 17: 343-351.
25. Solaro R, Gambassi G, Warshaw D, Keller M, Spurgeon H, Beier N et al. (1993). Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments. Circ Res 73: 981-990.
26. Tachibana H, Koga K, Fujimura Y, Yamada K (2004). A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 11: 380-381.
27. 2+. J Pharmacol Sci 97: 180P-180P.
28. 2+. Biophys J 88: 314a-314a.
29. Van Selst M, Jolicoeur P (1994). A solution to the effect of sample size on outlier elimination. Q J Exp Psychol A 47: 631-650.
30. Wang ZY, Wang LD, Lee MJ, Ho CT, Huang MT, Conney AH et al. (1995). Inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats by green and black tea. Carcinogenesis 16: 2143-2148.
31. 2+ sensitizing drug EMD 57033. J Biol Chem 276: 25456-25466.
32. Wen Y, Pinto JR, Gomes AV, Xu Y, Wang Y, Potter JD et al. (2008). Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice. J Biol Chem 283: 20484-20494.
33. Willott RH, Gomes AV, Chang AN, Parvatiyar MS, Pinto JR, Potter JD (2010). Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? J Mol Cell Cardiol 48: 882-892.
34. Wroblewski K, Muhandiram R, Chakrabartty A, Bennick A (2001). The molecular interaction of human salivary histatins with polyphenolic compounds. Eur J Biochem 268: 4384-4397.